Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$549K Buy
10,866
+1,083
+11% +$66.4K ﹤0.01% 1785
2026
Q1
$629K Buy
9,783
+1,569
+19% +$115K ﹤0.01% 1569
2025
Q4
$661K Sell
8,214
-832
-9% -$66.9K ﹤0.01% 1465
2025
Q3
$742K Sell
9,046
-102
-1% -$8.84K ﹤0.01% 1232
2025
Q2
$835K Buy
9,148
+2,489
+37% +$222K 0.01% 1074
2025
Q1
$605K Buy
6,659
+531
+9% +$46.3K 0.01% 1045
2024
Q4
$516K Buy
6,128
+3,435
+128% +$301K 0.01% 1064
2024
Q3
$236K Buy
+2,693
New +$227K ﹤0.01% 1223

Other funds holding DOX

&Partners's DOX Position: Q2 2026 in Review

&Partners increased its Amdocs (DOX) stake by 11% in Q2 2026, buying an estimated $66.4K and bringing the position to 10,866 shares worth $549K. The position accounts for ﹤0.01% of the portfolio, ranked #1785.

&Partners first reported a position in DOX in Q3 2024 and has held it in 8 quarters since. The position peaked at $835K in Q2 2025. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • &Partners held 10,866 shares of Amdocs worth $549K as of Q2 2026.
  • &Partners bought 1,083 Amdocs shares in Q2 2026, an estimated $66.4K.
  • Amdocs made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1785 holding.
  • &Partners first reported a position in Amdocs in Q3 2024 and has held it in 8 quarters since.
  • &Partners's Amdocs position peaked at $835K in Q2 2025.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.